SCHEDULE 13D

Company

Edesa Biotech, Inc.

Filed

June 25, 2019

Accession Number

0001144204-19-032265

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →